• LAST PRICE
    8.0500
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    7.7400/ 6
  • Ask / Lots
    8.2000/ 23
  • Open / Previous Close
    8.0500 / 8.0500
  • Day Range
    Low 7.9000
    High 8.2260
  • 52 Week Range
    Low 3.2100
    High 10.8150
  • Volume
    259,741
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 8.05
TimeVolumeVYGR
09:32 ET37598.05
09:35 ET2058.025
09:37 ET14007.98
09:39 ET2008.06
09:42 ET5008.11
09:44 ET3008.1
09:46 ET1008.15
09:48 ET15588.09
09:50 ET11008.03
09:51 ET7008.095
09:53 ET4008.05
10:02 ET3008.09
10:04 ET2008.05
10:06 ET9008.092
10:08 ET1008.14
10:09 ET12568.14
10:13 ET15628.155
10:18 ET10158.17
10:20 ET3008.18
10:24 ET1008.21
10:26 ET21368.17
10:31 ET1008.17
10:33 ET2008.17
10:36 ET2508.1719
10:38 ET2008.17
10:42 ET16288.21
10:44 ET1008.19
10:45 ET22008.13
10:47 ET16008.15
10:51 ET1008.17
10:54 ET3008.16
10:58 ET5308.13
11:00 ET9718.14
11:03 ET1008.1218
11:07 ET39768.04
11:09 ET21658.085
11:14 ET1008.08
11:18 ET10258.08
11:20 ET4128.075
11:21 ET4008.08
11:23 ET4008.08
11:25 ET1008.08
11:27 ET29038.055
11:30 ET4008.055
11:32 ET59758.025
11:34 ET69888.03
11:39 ET1048.055
11:41 ET2378.078
11:43 ET2008.05
11:45 ET17008.055
11:50 ET2008.08
11:56 ET6008.07
11:57 ET1008.05
11:59 ET1008.07
12:03 ET1008.07
12:06 ET2008.055
12:08 ET8008.04
12:12 ET24508.055
12:14 ET9588.05
12:15 ET2008.045
12:17 ET3008.04
12:19 ET7008.02
12:21 ET1008.025
12:24 ET2008.01
12:26 ET55747.99
12:32 ET25007.99
12:35 ET2007.99
12:37 ET17897.99
12:39 ET5338.0098
12:42 ET10008.005
12:46 ET5008.02
12:48 ET1008.04
12:50 ET8008.06
12:51 ET1008.07
01:02 ET26488.04
01:04 ET3508.045
01:06 ET2008.04
01:09 ET1008.04
01:11 ET5008.05
01:15 ET5408
01:18 ET18008.015
01:20 ET4008.0076
01:22 ET18068.015
01:24 ET10208.03
01:27 ET6008.005
01:29 ET2008
01:31 ET19888
01:33 ET11007.97
01:36 ET27547.985
01:40 ET109747.965
01:42 ET6288
01:44 ET6007.98
01:45 ET75307.93
01:49 ET2007.94
01:51 ET19217.93
01:56 ET8357.95
01:58 ET6007.95
02:02 ET21007.95
02:03 ET1007.94
02:07 ET5197.99
02:09 ET9988.02
02:14 ET4008.01
02:16 ET3328.01
02:18 ET6468.01
02:23 ET6048.02
02:25 ET1288.02
02:27 ET9008.01
02:30 ET15008.03
02:32 ET2008.04
02:34 ET15008.08
02:36 ET9008.06
02:38 ET1008.07
02:39 ET34008.1
02:41 ET17008.12
02:45 ET18008.14
02:48 ET31008.14
02:50 ET6888.15
02:52 ET16268.12
02:57 ET3008.12
03:01 ET2008.13
03:03 ET5008.12
03:06 ET2008.11
03:08 ET3008.085
03:10 ET6008.08
03:12 ET3008.09
03:14 ET6008.08
03:15 ET6008.08
03:19 ET5008.08
03:21 ET17098.095
03:24 ET5008.1
03:28 ET1008.1
03:30 ET13278.095
03:32 ET14328.08
03:33 ET7008.07
03:35 ET3908.06
03:37 ET1008.06
03:39 ET2008.06
03:42 ET23568.06
03:44 ET7008.055
03:46 ET2498.05
03:48 ET9008.06
03:50 ET53638.015
03:51 ET41358.04
03:53 ET21008.06
03:55 ET23038.06
03:57 ET42118.08
04:00 ET49758.05
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVYGR
Voyager Therapeutics Inc
310.8M
-17.4x
---
United StatesCCCC
C4 Therapeutics Inc
315.8M
-2.9x
---
United StatesADCT
ADC Therapeutics SA
350.7M
-2.1x
---
United StatesATAI
ATAI Life Sciences NV
320.1M
-1.5x
---
United StatesXOMA
XOMA Corp
233.6M
59.3x
---
United StatesMGTX
MeiraGTx Holdings PLC
395.6M
-3.1x
---
As of 2023-02-07

Company Information

Voyager Therapeutics, Inc. is a gene therapy company, which is focused on developing treatments and platform technologies. Its gene therapy platforms enable it to engineer, optimize, manufacture, and deliver its adeno-associated virus (AAV)-based gene therapies. It is identifying AAV capsids, the outer viral protein shells that enclose genetic material of a virus payload. It has developed a AAV capsid discovery platform, Tropism Redirection of AAV by Cell Type-Specific Expression of RNA (TRACER) to facilitate the selection of AAV capsids with blood brain barrier (BBB) crossing and cell-specific transduction properties for therapeutic applications. Its gene therapy programs include treatment programs for Huntington's disease, monogenic amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA), and various diseases linked to GBA1 mutations, including Parkinson's disease, Lewy body dementia and Gaucher's disease. It also focuses on tauopathies and indications in neuro-oncology.

Contact Information

Headquarters
64 SIDNEY STREETCAMBRIDGE, MA, United States 02139
Phone
857-259-5340
Fax
302-655-5049

Executives

Independent Chairman of the Board
Michael Higgins
Director
Alfred Sandrock
Chief Financial Officer
Peter Pfreundschuh
Chief Operating Officer
Robin Swartz
Senior Vice President, General Counsel
Robert Hesslein

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$310.8M
Revenue (TTM)
$70.5M
Shares Outstanding
38.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.14
EPS
$-0.46
Book Value
$2.51
P/E Ratio
-17.4x
Price/Sales (TTM)
4.4
Price/Cash Flow (TTM)
---
Operating Margin
-29.17%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.